Price T Rowe Associates Inc Homology Medicines, Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $5,055 - $11,347	-3,637 Reduced 5.22%	66,000 $130,000
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $5.81 Million - $9.32 Million	-2,234,846 Reduced 96.98%	69,637 $212,000
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $144,959 - $309,830	39,824 Added 1.76%	2,304,483 $8.39 Million
Q2 2021 Aug 16, 2021	SELL	$6.02 - $9.64 $2.57 Million - $4.12 Million	-427,002 Reduced 15.86%	2,264,659 $16.5 Million
Q1 2021 May 17, 2021	BUY	$9.17 - $14.8 $6.47 Million - $10.4 Million	705,363 Added 35.51%	2,691,661 $25.3 Million
Q4 2020 Feb 16, 2021	BUY	$8.92 - $13.29 $17.7 Million - $26.4 Million	1,986,298 New	1,986,298 $22.4 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.